← SynDRA
PHA-793887
SynDRA canonical compound SYN0024163 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | CDK1 |
|---|
| Mechanism of action | CDK inhibitor |
|---|
All known targets
- CDK1
- CDK4
- CDK2
- CDK9
- CDK7
- CDK5
- CDK19
- CDK8
- CDK6
- CDK3
- CDK20
- CCND1
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- CDK1 INHIBITOR
- CDK4/6 inhibitor
- CDK2 INHIBITOR
- CDK5 INHIBITOR
- CDK7 INHIBITOR
- CDK3 INHIBITOR
- CDK16 INHIBITOR
- CDK18 INHIBITOR
- CDK8 INHIBITOR
- CDK17 INHIBITOR
- CDK11B INHIBITOR
Cross-references
Synonyms
- Cyclin-dependent kinase inhibitor (cancer), Nerviano
- MKS45S912B
- PHA793887
- RefChem:172367
- DTXCID50144625
- C19H31N5O2
- UNII-MKS45S912B
- MFCD17169992
- MLS006010173
- orb1306453
- SCHEMBL5110328
- CHEBI:91371
- GLXC-07840
- HMS3265M13
- HMS3265M14
- HMS3265N13
- HMS3265N14
- HMS3654B16
- EX-A2134
- BDBM50378657
- NSC800851
- AKOS015995002
- CCG-264898
- NSC-800851
- SB19463
- SDCCGSBI-0654372.P001
- PHA-793887?
- NCGC00263168-01
- NCGC00263168-04
- NCGC00263168-05
- NCGC00263168-06
- AC-32848
- AS-19371
- FM145343
- HY-11001
- SMR004701281
- DB-074487
- NS00072623
Look up PHA-793887 in the interactive SynDRA portal →